ArticleCancer management and research2025
Integrating Deep Learning and Radiomics in Differentiating Papillary Thyroid Microcarcinoma from Papillary Thyroid Carcinoma with Ultrasound Images.
Article in Cancer management and research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Revolutionizing thyroid nodule diagnosis in Hashimoto's thyroiditis: AI-driven radiomics and deep learning model.International journal of surgery (London, England) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The feasibility and accuracy of ultrasound-based radiomics, deep learning, and combined deep learning radiomics models were investigated in the differentiation of papillary thyroid carcinoma and papillary thyroid microcarcinoma to decrease the risk of overtreatment of papillary thyroid microcarcinoma. Methods: A total of 549 patients with confirmed 180 papillary thyroid carcinoma and 436 papillary thyroid microcarcinoma nodules from Hospital One were enrolled and randomly divided into training and validation cohorts at a ratio of 8:2 with 56 patients left as independent testing set 1. Fifty patients from Hospital Two were enrolled as independent testing set 2. Radiomics signature and five deep learning networks, such as visual geometry group 13 (VGG13), VGG16, VGG19, AlexNet, and EfficientNet, were generated for papillary thyroid carcinoma and papillary thyroid microcarcinoma differentiation. Combined deep learning and radiomics models were constructed to further improve the differentiation ability. Results: An area under curves of 0.826 and 0.822 was achieved with radiomics model for papillary thyroid carcinoma and papillary thyroid microcarcinoma differentiation in the independent testing set 1 and set 2, respectively. VGG19 achieved the best area under curves of 0.890 and EfficientNet achieved the best accuracy of 0.867. The best accuracy and area under curves of 0.904, 0.900, and 0.931, 0.946 were achieved with the combination of VGG + radiomics (R_V_Combined) and EffiecientNet + radiomics (R_E_Combined) in the independent testing set 1 and set 2, respectively. Conclusion: Deep learning and radiomics combination models are promising in the noninvasively preoperative differentiation of papillary thyroid microcarcinoma and papillary thyroid carcinoma to decrease the overtreatment of patients with papillary thyroid microcarcinoma and to minimize the complications caused by overtreatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.